Solid Biosciences Inc (SLDB)
10.29
+0.04
(+0.39%)
USD |
NASDAQ |
May 03, 13:55
Solid Biosciences Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.014M |
December 31, 2021 | 0.11M |
Date | Value |
---|---|
September 30, 2021 | 0.594M |
June 30, 2021 | 0.286M |
March 31, 2021 | 0.28M |
December 31, 2020 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
0.594M
Maximum
Sep 2021
0.1605M
Average
0.062M
Median
Accounts Receivable (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 378.81M |
PTC Therapeutics Inc | 197.66M |
Capricor Therapeutics Inc | 10.37M |
Perspective Therapeutics Inc | 1.165M |
Electromed Inc | 22.99M |